Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration
Materials Today Bio · 2025-10 · 34 · 102144
DOI: 10.1016/j.mtbio.2025.102144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-10. Verfasst von Shan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Orthopaedics, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuita…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Health Commission, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Bone regeneration remains a clinical challenge due to the inherent limitations of conventional grafts and synthetic materials. While mRNA-based strategies offer promising therapeutic potential, their clinical application is hindered by systemic delivery barriers and rapid degradation. Here, we present a hybrid extracellular vesicle (EV)-GelMA hydrogel system for the localized delivery of VEGFA mRNA to enhance both angiogenesis and osteogenesis through precise spatiotemporal control. In vitro, the VEGFA-EVs-GelMA system significantly enhanced migration and osteogenic differentiation of pre-osteoblastic cells, as evidenced by upregulation of ALP, RUNX2, and OPN expression compared to GelMA controls. In a rat cranial defect model, the VEGFA-EVs-GelMA group showed a marked increase in bone volume/total volume (BV/TV), supported by microcomputed tomography (Micro-CT), at both 4 and 8 weeks post-implantation. Mechanistically, this dual-component platform leverages the biomolecular protection and targeted delivery afforded by EVs, together with the tunable release properties of GelMA hydrogels, to overcome key mRNA delivery barriers. Our results highlight the potential of this system as a clinically translatable strategy for promoting vascularized bone regeneration and provide new insights for the treatment of complex bone defects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Orthopaedics, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
- Department of Cardiovascular Surgery for the First Affiliated Hospital & Institute for Cardiovascular Science, Suzhou Medical College, Soochow University, Suzhou, China.
- Department of Orthopaedics, National Center for Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Förderung
- Beijing Municipal Health Commission
- Beijing Natural Science Foundation
Zitieren
APA
Li, S., Sheng, Y., You, Y., Wang, Y., Zhang, Y., Tao, J., Wu, C., & Jiang, X. (2025). Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration. Materials Today Bio, 34, 102144. https://doi.org/10.1016/j.mtbio.2025.102144
Vancouver
Li S, Sheng Y, You Y, Wang Y, Zhang Y, Tao J, et al. Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration. Materials Today Bio. 2025;34:102144. doi:10.1016/j.mtbio.2025.102144
BibTeX
@article{Li2025,
author = {Li, Shan and Sheng, Yueyang and You, Yi and Wang, Ying and Zhang, Yanzhuo and Tao, Jianfeng and Wu, Chengai and Jiang, Xu},
title = {Study on VEGFA mRNA delivery via GelMA hydrogel-encapsulated extracellular vesicles for enhanced bone regeneration},
journal = {Materials Today Bio},
year = {2025},
volume = {34},
pages = {102144},
doi = {10.1016/j.mtbio.2025.102144}
}
EUVIMED